Burning Rock Biotech (BNR) Total Debt (2019 - 2025)

Burning Rock Biotech's Total Debt history runs 5 years deep, the most recent figure standing at $267885.9 for Q4 2025.

• In Q4 2025, Total Debt changed N/A year-over-year to $267885.9; the TTM figure through Dec 2025 stood at $267885.9 (changed N/A YoY), while the FY2025 annual figure was $267885.9, changed N/A from the prior year.
• Total Debt was $267885.9 for Q4 2025 at Burning Rock Biotech, up from $251492.2 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $211.9 million in Q2 2022 to a low of $251492.2 in Q3 2025.
• Historically, Total Debt has averaged $51.9 million across 3 years, with a median of $4.7 million in 2021.
• The sharpest annual moves came in 2021 and 2022: Total Debt dropped 28.69% in 2021, then surged 4441.87% in 2022.
• A 3-year view of Total Debt shows it stood at $140.8 million in 2021, then surged by 50.51% to $211.9 million in 2022, then sank by 99.87% to $267885.9 in 2025.
• The last three Total Debt figures came in at $267885.9 (Q4 2025), $251492.2 (Q3 2025), and $276505.5 (Q2 2025), per Business Quant data.